Skip to main content
ORNL’s Prasanna Balaprakash joined leading computing experts to provide insight into how supercomputing, AI and meteorology can work together to advance weather and climate research as part of a panel for the United States Senate.

Prasanna Balprakash, director of AI programs for ORNL, discussed advancing climate and weather research through high performance computing and artificial intelligence as part of a September 18 panel for the United States Senate. 

A team led by Oak Ridge National Laboratory researchers used Frontier to explore training strategies for one of the largest artificial intelligence models to date. Credit: Getty Images

A team led by researchers at ORNL explored training strategies for one of the largest artificial intelligence models to date with help from the world’s fastest supercomputer. The findings could help guide training for a new generation of AI models for scientific research.
 

Prasanna Balaprakash, who leads ORNL’s AI Initiative, participated in events hosted by the White House Office of Science and Technology Policy and the Task Force on American Innovation to discuss the challenges and opportunities posed by AI. Credit: Brian Mosley/Computing Research Association

In summer 2023, ORNL's Prasanna Balaprakash was invited to speak at a roundtable discussion focused on the importance of academic artificial intelligence research and development hosted by the White House Office of Science and Technology Policy and the U.S. National Science Foundation.

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.